TYRA (Tyra Biosciences, Inc.) Earnings growth in current year

Official company branding of tyra.bio (TYRA)

High demand for innovative methods to combat resistant tumors is driving the expansion of Tyra Biosciences, Inc. (TYRA). The annual percentage growth of earnings per share visualizes this potential, with the latest figure standing at -39.60. The development of the SNAP platform for the treatment of achondroplasia combines with the implementation of ESG standards for bio-waste recycling, which stabilizes the issuer's internal operational processes.

TYRA (Tyra Biosciences) Earnings growth in current year history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Tyra Biosciences, Inc. (TYRA)

- share price and expert price forecast:
Fundamental valuation:TYRA Tyra Bio
Signature product of Tyra Corp

This indicator measures the annual rate of change in earnings per share, allowing for an assessment of sustainable financial growth while filtering out market noise. By analyzing EPS dynamics compared to the previous year, an investor can gauge the capitalization efficiency of the SNAP platform, where the diversification of targeted oncology therapies reduces clinical risks and directly impacts the fundamental business value of Tyra Biosciences, Inc. (TYRA).

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year ELVN (Enliven Therapeutics Inc)|Net earnings per share change in current year ORIC Pharma|Relay Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Nurix Therapeutics, Inc.|VSTM (Verastem, Inc.) - Net earnings per share growth this year|GLUE: Net earnings per one share growth for the current year|CGEM (cullinanoncology.com) - Earnings growth in current year|Earnings per share growth rate in current year Immuneering Inc. IMRX|Earnings growth in current year CCCC|Black Diamond Therapeutics - Earnings per share growth this year|Repare Therapeutics Inc. - Net earnings per share growth this year|Earnings per share increase in current year PMVP|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year